Beacon Discovery, Takeda Ink Deal

San Diego’s Beacon Discovery formed a multi-year drug discovery collaboration with Takeda Pharmaceutical Company centered on gastrointestinal disorders.

Okogen Receives $10 Million for Pink Eye Treatment

San Diego’s Okogen received $10 million in Series A funding to advance the company’s lead candidate for viral conjunctivis, commonly known as pink eye.

Ionis Reports Big Gains in Q4, Full 2017 Results

Ionis Pharmaceuticals in Carlsbad Reported $508 million in 2017 revenue, a 46.3 percent increase over the previous year, driven by rising drug royalties.

Oceanside Medical Building Sold

Medical group will remain as tenants.

Tease photo

NuVasive Reports Q4 Results

Spine surgery and medical device maker NuVasive reported revenue of $271.1 million in the fourth quarter for flat year-over-year growth.

Neuroscience May Belong to the Nimble

MEDICINE: Big Players Bail, But Midsize Cos. Aim for Next Big Thing

Amid big pharma’s waning commitment to neurological disorders like Alzheimer’s, San Diego startups and midstage biotechs see opportunity.

Tease photo

UC San Diego Health Selects Model, Launches Its ACO

MEDICINE: System Is Betting On Treatment Strategies Success

UC San Diego Health has launched a Medicare program that brings the potential for health system savings — that is, if it can meet care and cost requirements.

Tease photo

John DeFord to Join NuVasive Board

With DeFord’s appointment, the board will have 10 directors, nine of whom are independent.

Ionis Licenses Kidney Drug in Deal Worth up to $330M

Carlsbad’s Ionis Pharmaceuticals has licensed a kidney drug to British giant AstraZeneca, earning $30 million upfront and the potential for $300 million in development and regulatory milestone payments.

Health-Tech Fundraising Focus of Upcoming SDVG Event

Life sciences entrepreneur Dena Marranuci, who leads corporate development and research and development at Truvian Sciences, will moderate a discussion about raising early-stage capital.

AMN Healthcare Reports Solid Growth

Medical staffing company AMN Healthcare reported 2017 fourth quarter revenue of $509 million, a 4 percent year-over-year increase.

Tandem Diabetes Care Gains Distribution Outside U.S.

San Diego’s Tandem Diabetes Care inked a European distribution deal with Rubin Medical, meaning its insulin pumps will be sold outside the U.S. for the first time.

Dexcom Pilot Program Targets Type 2 Diabetes Population

DEVICES: Company Gains Advantage By Partnering With Insurer

Dexcom aspires to widen its reach beyond Type 1 diabetes. Recently, the San Diego company took a big step toward the goal.

Tease photo

PE Firm With SoCal Focus Raises $300M Fund

The firm has two San Diego companies in its eight-company portfolio.

First Blood Test to Evaluate Concussions Receives Green Light

A first-ever test from San Diego’s Banyan Biomarkers to help doctors diagnose traumatic brain injuries has won Federal Drug Administration approval.